Indegene Limited (NSE:INDGN)

Market Cap	133.60B
Revenue (ttm)	29.24B
Net Income (ttm)	4.35B
Shares Out	240.01M
EPS (ttm)	18.07
PE Ratio	30.81
Forward PE	27.35
Dividend	2.00 (0.36%)
Ex-Dividend Date	Jun 13, 2025

Volume	106,121
Average Volume	383,323
Open	551.10
Previous Close	553.50
Day's Range	549.50 - 557.90
52-Week Range	499.00 - 735.00
Beta	n/a
RSI	42.22
Earnings Date	Oct 28, 2025

About Indegene

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1998
• Employees: 4,158
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDGN

Financial Performance

In 2024, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.